Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Pharmacol ; 63(10): 1133-1140, 2023 10.
Article in English | MEDLINE | ID: mdl-37474123

ABSTRACT

Lenvatinib is a medication that targets multiple tyrosine kinases and is commonly used to treat various types of cancer. With its frequent usage, monitoring and assessing its potential adverse effects has become crucial. This study utilizes the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to analyze the possible link between lenvatinib and gastrointestinal perforation. FAERS was used to analyze adverse drug reactions (ADRs) linked with lenvatinib from the first quarter of 2015 to the last quarter of 2022. The association between lenvatinib and gastrointestinal perforation was evaluated using disproportionality analyses. This study included 464 patients who developed gastrointestinal perforation after using lenvatinib. Perforation involved the entire digestive tract, with the colon among the most commonly affected perforation sites, and previously undetected esophageal perforation was frequently observed. Patients with uterine and liver cancer were at a higher risk of developing gastrointestinal perforation; patients with liver cancer experienced a shorter onset time, whereas patients with endometrial cancer had a slower onset time. Middle-aged and elderly patients exhibited a higher propensity for developing gastrointestinal perforation than younger adults. Patients with gastrointestinal perforation were found to have a significantly higher mortality rate than patients without gastrointestinal perforation. This study has identified several gastrointestinal perforation events not included in the drug instructions. It has also described the perforation site and clinical characteristics based on various types of cancer. These results could provide valuable insights for developing safer and more effective regulatory strategies concerning the use of lenvatinib.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Liver Neoplasms , Quinolines , Adult , Aged , Middle Aged , United States/epidemiology , Humans , United States Food and Drug Administration , Pharmacovigilance , Quinolines/adverse effects , Databases, Factual , Adverse Drug Reaction Reporting Systems
2.
Phys Rev Lett ; 126(22): 223603, 2021 Jun 04.
Article in English | MEDLINE | ID: mdl-34152162

ABSTRACT

The breaking of reciprocity is a topic of great interest in fundamental physics and optical information processing applications. We demonstrate nonreciprocal light transport in a quantum system of hot atoms by engineering the dissipative atomic reservoir. Our scheme is based on the phase-sensitive light transport in a multichannel photon-atom interaction configuration, where the phase of collective atomic excitations is tunable through external driving fields. Remarkably, we observe interchannel quantum correlations that originate from interactions with the judiciously engineered reservoir. The nonreciprocal transport in a quantum optical atomic system constitutes a new paradigm for atom-based nonreciprocal optics and offers opportunities for quantum simulations with coupled optical channels.

3.
Phys Rev Lett ; 124(3): 030401, 2020 Jan 24.
Article in English | MEDLINE | ID: mdl-32031853

ABSTRACT

Recent advances in non-Hermitian physical systems have led to numerous novel optical phenomena and applications. Such systems typically involve gain and loss associated with dissipative coupling to the environment, hence interesting quantum phenomena are often washed out, rendering most realizations classical. Here, in contrast, we propose to employ dissipative coupling to enable quantum correlations. In particular, two distant optical channels are judiciously designed to couple to and exchange information with a common reservoir environment, under an anti-parity-time-symmetric setting of hot but coherent atoms. We realize a non-Hermitian nonlinear phase sensitive parametric process, where atomic motion leads to quantum correlations between two distant light beams in the symmetry-unbroken phase. This Letter starts a new route to exploring the non-Hermitian quantum phenomena by bridging the fields of atomic physics, non-Hermitian optics, quantum information, and reservoir engineering. Potential applications include novel quantum light sources, quantum information processing and sensing, and generalization to correlated many-body systems.

SELECTION OF CITATIONS
SEARCH DETAIL
...